CrossRef Post-Translational Modification Networks in Ferroptosis: Orchestrating Defense, Drug Resistance, and Therapeutic Opportunities in Hepatocellular Carcinoma Jie Chen, Lingling Li, Sufang Fang, Haitao Zhou Journal of Hepatocellular Carcinoma .2026
Take home message To be absolutely clear: taking Wegovy every other week is experimental, lacks any clinical validation, and could potentially compromise your health outcomes and safety
We know that weight loss is about more than just a number on a scale
The rationale for titrating upward over time, rather than starting at the target dose, mirrors the approach taken with other metabolic peptides: the goal is to identify the minimum effective dose for each individual while monitoring for tolerability
Additionally, nutrition is crucial for your well-being, and eating too many highly processed, low-nutrition foods, such as candy and pastries, can derail both your nutrition and weight-loss efforts